菌体疗法调节肠道微生物群和免疫反应在非伤寒型沙门氏菌诱导的大肠炎
Md Sharifull Islam1, Ping Wei2, Kaimin Zhang3
1Center for Cancer Immunology, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS), 1068 Xueyuan Avenue, Shenzhen 518055, China; Department of Microbiology, Stamford University Bangladesh, 51, Siddeswari Road, Dhaka, 1217, Bangladesh.
Food research international (Ottawa, Ont.)
|September 9, 2025
概括
使用FPSP6的菌体疗法通过减少炎症和改善免疫标志物,有效地治疗了小鼠的沙门氏菌诱导大肠炎. 这表明菌体疗法是抗生素对由食物传播病原体引起的肠道炎症的有希望的替代品.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 炎症性肠病 (IBD) 包括克罗恩氏病和性结肠炎.
- 食物传播的病原体,如沙门氏菌,正在研究它们在IBD中的作用.
- 菌体治疗提供向的细菌治疗,并对沙门氏菌诱导的大肠炎进行了探索.
研究的目的:
- 在沙门氏菌引起的大肠炎的小鼠模型中评估菌体治疗的疗效.
- 研究一种新的沙门氏菌特异性菌体FPSP6.6的免疫调节机制.
- 建立菌体疗法作为肠道炎症抗生素的潜在替代品.
主要方法:
- 在小鼠中使用Salmonella typhimurium诱导大肠炎.
- 管理沙门氏菌特异性菌体FPSP6.6.
- 评估结肠炎的严重程度 (结肠长度,细胞因子水平) 和免疫细胞群 (CD4+ T细胞).
- 代谢分析以了解治疗效果.
主要成果:
- 沙门氏菌感染加剧了结肠炎,其特征是结肠短,炎症性细胞因子增加.
- FPSP6治疗显著减轻了结肠炎的严重程度.
- 菌体治疗减少了肠道炎症,增加了CD4+T细胞水平,减少了细胞因子的表达.
- 代谢数据支持FPSP6.6的治疗疗效.
结论:
- 在小鼠模型中,用FPSP6进行菌体治疗对于治疗沙门氏菌诱导的大肠炎是有效和安全的.
- FPSP6表现出免疫调节作用,影响免疫细胞水平和细胞因子的产生.
- 用菌体疗法准肠道微生物群为抗生素提供了一个可行的替代方案,用于管理由食物传播的病原体引起的肠道炎症.
相关概念视频
01:28Gene Regulation in Microbial Communities: Quorum Sensing
534
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
534
01:29Microorganisms in Medicine and Therapeutics
989
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
989
00:43Lysogenic Cycle of Bacteriophages
67.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
67.3K
01:30Lytic Cycle of Bacteriophages
77.5K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.5K